Home
About
Overview
Sharing Data
ORCID
Help
History (31)
Predicting stroke risk after sepsis hospitalization with new-onset atrial fibrillation.
Peptidylarginine deiminase inhibition reduces vascular damage and modulates innate immune responses in murine models of atherosclerosis.
Cardiac Structure and Function in Hyperaldosteronism.
Quantifying and understanding the fitness effects of protein mutations: Laboratory versus nature.
Cost-effectiveness of TAVR in the non-surgical population.
See All 31 Pages
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Cost-effectiveness of TAVR in the non-surgical population.
Reardon MJ, Reynolds MR. Cost-effectiveness of TAVR in the non-surgical population. J Med Econ. 2013; 16(4):575-9.
View in:
PubMed
subject areas
Aortic Valve Stenosis
Health Services
Heart Valve Prosthesis Implantation
Humans
authors with profiles
Matthew R Reynolds MD, MSc